Compare TBPH & EPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | EPC |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 918.9M |
| IPO Year | 2013 | 1999 |
| Metric | TBPH | EPC |
|---|---|---|
| Price | $16.75 | $22.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $18.40 | ★ $23.33 |
| AVG Volume (30 Days) | 342.9K | ★ 453.9K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ 279.13 | N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | $15,386,000.00 | ★ $2,223,500,000.00 |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | N/A | $1.64 |
| P/E Ratio | $8.13 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.33 | $15.88 |
| 52 Week High | $21.03 | $30.79 |
| Indicator | TBPH | EPC |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 52.33 |
| Support Level | $16.14 | $18.95 |
| Resistance Level | $17.24 | $24.18 |
| Average True Range (ATR) | 0.41 | 0.75 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 56.56 | 29.96 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. Sun and Skin Care consists of sun care products, men's and women's grooming products, Billie women's grooming products and personal wipe products. Feminine Care products include tampons, pads and liners. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.